What does agenus company do?
Agenus is an immuno-oncology company focused on the discovery and development of revolutionary new treatments that engage the body’s immune system to benefit patients suffering from cancer.
What drugs does agenus make?
Agenus has programs targeting the checkpoint modulators GITR, OX40, CTLA-4, LAG-3, TIM-3 and PD-1. The company is expanding that portfolio by using a proprietary process to generate fully human therapeutic antibody drug candidates.
What industry is Agenus?
immuno-oncology company
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally.
Who is the founder of agenus?
Garo H. Armen
Agenus/Founders
Is agenus a good stock to buy?
Agenus has received a consensus rating of Buy.
What is immuno oncology therapy?
Cancer immunotherapy, also known as immuno-oncology, is a form of cancer treatment that uses the power of the body’s own immune system to prevent, control, and eliminate cancer. Immunotherapy can: Educate the immune system to recognize and attack specific cancer cells.
Why is agenus stock up?
Why Agenus Was Rising High on Tuesday In mid-afternoon trading, the company’s shares were up by 7.5% on the back of an encouraging earnings report. It also earned a net profit — specifically, $177.3 million ($0.72 per share), a dramatic improvement over the nearly $52 million the company lost in Q3 2020.
When was agenus Inc founded?
March 31, 1994
Agenus/Founded
Agenus Inc (NASDAQ:AGEN) The company was founded by Garo H. Armen and Pramod K. Srivastava in March 31, 1994 and is headquartered in Lexington, MA.
Why did Agen go down?
Agenus (AGEN) has been beaten down lately with too much selling pressure. While the stock has lost 33.3% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnings than they predicted earlier.
Why did Agen stock go up?
Why Agenus Was Rising High on Tuesday In mid-afternoon trading, the company’s shares were up by 7.5% on the back of an encouraging earnings report.
Is immunotherapy a cure?
Not a cure, but an extension: How immunotherapy works for advanced lung cancer. Immunotherapy doesn’t usually cure advanced lung cancer, but it can give some patients more time with family and friends. For nearly five decades, doctors have used various forms of immunotherapy to treat certain cancers.
